Table 1.
Summary of FoxC2 expression and prognosis in human cancer.
Tumor type | Number | FoxC2 expression | Prognosis |
---|---|---|---|
Melanoma [15] | Vascular endothelial cells | Not evaluated | |
Breast, colon [15] | Adenocarcinoma | Not evaluated | |
Esophageal [39] | 70 | Cytoplasm of cancer cells | 5-year survival: 70% FoxC2 (low); 30% FoxC2 (high) |
Breast [40] | 18 | Highly aggressive basal-like tumors | Not evaluated |
Breast [41] | CD44high/CD24lowcells | Not evaluated |